BG62794B1 - Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество - Google Patents

Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество Download PDF

Info

Publication number: BG62794B1
Authority: BG; Bulgaria
Prior art keywords: carbamazepine; film; ratio; plasticizer; carbamasepin
Prior art date: 1994-07-01

Application number

BG101080A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG101080A (en

Inventor

Karl-Friedrich Landgraf

Sabine Reiss

Eberhard Schubert

Original Assignee

Arzneimittelwerk Dresden Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-07-01

Filing date

1996-12-28

Publication date

2000-08-31

1996-12-28 Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh

1997-08-29 Publication of BG101080A publication Critical patent/BG101080A/xx

2000-08-31 Publication of BG62794B1 publication Critical patent/BG62794B1/bg

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BG101080A 1994-07-01 1996-12-28 Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество BG62794B1 (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19944423078 DE4423078B4 (de)	1994-07-01	1994-07-01	Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de)	1994-07-01	1995-06-22	Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number	Publication Date
BG101080A BG101080A (en)	1997-08-29
BG62794B1 true BG62794B1 (bg)	2000-08-31

Family

ID=6522000

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG101080A BG62794B1 (bg)	1994-07-01	1996-12-28	Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество

Country Status (23)

Country	Link
US (1)	US5888545A (xx)
EP (1)	EP0768882B1 (xx)
JP (1)	JPH10502358A (xx)
KR (1)	KR100344477B1 (xx)
CN (1)	CN1101191C (xx)
AT (1)	ATE169818T1 (xx)
BG (1)	BG62794B1 (xx)
BR (1)	BR9508202A (xx)
CA (1)	CA2194216A1 (xx)
CZ (1)	CZ288028B6 (xx)
DE (2)	DE4423078B4 (xx)
DK (1)	DK0768882T3 (xx)
EE (1)	EE03954B1 (xx)
ES (1)	ES2122630T3 (xx)
GE (1)	GEP19991819B (xx)
HU (1)	HU221486B (xx)
LT (1)	LT4251B (xx)
LV (1)	LV11820B (xx)
PL (1)	PL180979B1 (xx)
RU (1)	RU2141825C1 (xx)
SK (1)	SK282303B6 (xx)
UA (1)	UA32598C2 (xx)
WO (1)	WO1996001112A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6162466A (en) *	1999-04-15	2000-12-19	Taro Pharmaceutical Industries Ltd.	Sustained release formulation of carbamazepine
GB9930058D0 (en) *	1999-12-20	2000-02-09	Novartis Ag	Organic compounds
RU2240798C1 (ru) *	2003-06-25	2004-11-27	Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"	Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
AU2006239838A1 (en) *	2005-04-25	2006-11-02	Teva Pharmaceuticals Usa, Inc.	Extended release formulations
DK1940467T3 (da) *	2005-09-09	2017-02-13	Paladin Labs Inc	Lægemiddelsammensætning med langvarig frigivelse
SI1931346T1 (sl) *	2005-09-09	2012-10-30	Angelini Labopharm Llc	Trazodonski sestavek za dajanje enkrat dnevno
US20070160960A1 (en) *	2005-10-21	2007-07-12	Laser Shot, Inc.	System and method for calculating a projectile impact coordinates
RU2361591C1 (ru) *	2007-10-03	2009-07-20	Общество с ограниченной ответственностью "Научно-производственное объединение "Фарматрон" (НПО "Фарматрон")	Противосудорожное лекарственное средство
FR2940910A1 (fr) *	2009-01-09	2010-07-16	Vetoquinol Sa	Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) *	2016-07-19	2016-10-12	南京正宽医药科技有限公司	一种卡马西平片及其制备方法
CN108125922A (zh) *	2018-01-14	2018-06-08	上海安必生制药技术有限公司	一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) *	1982-06-24	1982-06-24	Astra Laekemedel Ab	Pharmaceutical mixture
DK151608C (da) *	1982-08-13	1988-06-20	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) *	1986-08-07	1988-12-15	Ciba Geigy Ag	Therapeutisches system mit systemischer wirkung.
IL86211A (en) *	1987-05-04	1992-03-29	Ciba Geigy Ag	Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) *	1989-03-23	1994-07-05	Fmc Corporation	Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

1994
- 1994-07-01 DE DE19944423078 patent/DE4423078B4/de not_active Expired - Fee Related
1995
- 1995-06-22 ES ES95922407T patent/ES2122630T3/es not_active Expired - Lifetime
- 1995-06-22 BR BR9508202A patent/BR9508202A/pt not_active Application Discontinuation
- 1995-06-22 CN CN95193915A patent/CN1101191C/zh not_active Expired - Fee Related
- 1995-06-22 AT AT95922407T patent/ATE169818T1/de active
- 1995-06-22 RU RU97101469A patent/RU2141825C1/ru active
- 1995-06-22 DE DE59503283T patent/DE59503283D1/de not_active Expired - Lifetime
- 1995-06-22 UA UA97010403A patent/UA32598C2/uk unknown
- 1995-06-22 SK SK1646-96A patent/SK282303B6/sk not_active IP Right Cessation
- 1995-06-22 JP JP8503611A patent/JPH10502358A/ja not_active Ceased
- 1995-06-22 EE EE9600202A patent/EE03954B1/xx unknown
- 1995-06-22 CZ CZ19963826A patent/CZ288028B6/cs not_active IP Right Cessation
- 1995-06-22 HU HU9603565A patent/HU221486B/hu unknown
- 1995-06-22 DK DK95922407T patent/DK0768882T3/da active
- 1995-06-22 WO PCT/DE1995/000805 patent/WO1996001112A1/de not_active Ceased
- 1995-06-22 PL PL95317996A patent/PL180979B1/pl unknown
- 1995-06-22 US US08/776,266 patent/US5888545A/en not_active Expired - Lifetime
- 1995-06-22 CA CA002194216A patent/CA2194216A1/en not_active Abandoned
- 1995-06-22 KR KR1019960707549A patent/KR100344477B1/ko not_active Expired - Lifetime
- 1995-06-22 GE GEAP19953512A patent/GEP19991819B/en unknown
- 1995-06-22 EP EP95922407A patent/EP0768882B1/de not_active Expired - Lifetime
1996
- 1996-12-28 BG BG101080A patent/BG62794B1/bg unknown
1997
- 1997-01-30 LT LT97-012A patent/LT4251B/lt not_active IP Right Cessation
- 1997-01-30 LV LVP-97-13A patent/LV11820B/lv unknown

Also Published As

Publication number	Publication date
BG101080A (en)	1997-08-29
CN1101191C (zh)	2003-02-12
HU221486B (en)	2002-10-28
UA32598C2 (uk)	2001-02-15
BR9508202A (pt)	1997-11-11
HU9603565D0 (en)	1997-02-28
CZ288028B6 (cs)	2001-04-11
HUT76821A (en)	1997-11-28
GEP19991819B (en)	1999-11-05
KR970703774A (ko)	1997-08-09
LT4251B (en)	1997-12-29
LV11820B (en)	1997-12-20
PL317996A1 (en)	1997-05-12
WO1996001112A1 (de)	1996-01-18
CZ382696A3 (en)	1997-05-14
DE59503283D1 (de)	1998-09-24
DE4423078B4 (de)	2005-01-13
LT97012A (en)	1997-08-25
EP0768882A1 (de)	1997-04-23
SK282303B6 (sk)	2002-01-07
RU2141825C1 (ru)	1999-11-27
SK164696A3 (en)	1997-06-04
LV11820A (lv)	1997-08-20
KR100344477B1 (ko)	2002-11-23
EE9600202A (et)	1997-06-16
DE4423078A1 (de)	1996-01-04
JPH10502358A (ja)	1998-03-03
DK0768882T3 (da)	1999-05-25
PL180979B1 (pl)	2001-05-31
EE03954B1 (et)	2003-02-17
EP0768882B1 (de)	1998-08-19
ATE169818T1 (de)	1998-09-15
CA2194216A1 (en)	1996-01-18
CN1153475A (zh)	1997-07-02
ES2122630T3 (es)	1998-12-16
US5888545A (en)	1999-03-30

Publication	Publication Date	Title
EP0342522B1 (en)	1991-12-18	Peroral preparation of an acid-unstable compound
KR930003114B1 (ko)	1993-04-19	2상성의 방출 단면을 가진 제어 방출되는 경구용 제제의 제조방법
ES2226886T3 (es)	2005-04-01	Forma de administracion de accion retardada que contiene sacarinato de tramadol.
JP2653996B2 (ja)	1997-09-17	徐放性薬剤
AU2003269067A1 (en)	2004-02-16	Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
JP2001522874A (ja)	2001-11-20	オメプラゾールの配合物
SE509029C2 (sv)	1998-11-30	Långtidsverkande diklofenak-natriumpreparat
AU2003269068A1 (en)	2004-02-16	Micropcapsules with modified release of active principles with low solubility for oral delivery
KR20010074914A (ko)	2001-08-09	오메프라졸 제형
PT93029A (pt)	1990-08-31	Processo para a preparacao de uma composicao contendo acido 5-(2,5- dimetilfenoxi)-2,2-dimetil-pentanoico (gemfibrozilo) de libertacao modificada
BG62794B1 (bg)	2000-08-31	Метод за получаване на лекарствена форма на карбамазепин съсзабавено освобождаване на активното вещество
JPH0157090B2 (xx)	1989-12-04
US20020076444A1 (en)	2002-06-20	Novel method for obtaining microspheres and resulting products
WO1995025516A1 (en)	1995-09-28	Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
JPH06503577A (ja)	1994-04-21	医薬組成物
JPS58116414A (ja)	1983-07-11	ニカルジピン持続性製剤用球形顆粒およびその製造法
JPH07112932A (ja)	1995-05-02	徐放性医薬製剤
JPS59227817A (ja)	1984-12-21	持続性経口用ブレデニン製剤
AU6224699A (en)	2000-10-09	Taste masking coating compositions
JPH07118154A (ja)	1995-05-09	固体分散体および粒状製剤
JPH06305960A (ja)	1994-11-01	チオウレア誘導体含有固形製剤
JPS6141325B2 (xx)	1986-09-13
JPH11269064A (ja)	1999-10-05	胃・十二指腸付着性医薬組成物
JPS6024765B2 (ja)	1985-06-14	セフアレキシンの持続性製剤の製造方法
KR960008232B1 (ko)	1996-06-21	오메프라졸 액제